Oue Limited · SGX:LJ3
Oue — OUE Healthcare — Merger or Acquisition (August 2026)
16 slides from Oue's merger presentation, Aug 24, 2026
Slide 1: OUE Limited's Proposed Privatisation of OUE Healthcare Limited
OUE Limited’s Proposed Privatisation of OUE Healthcare Limited Investor Presentation 24 August 2026 Strictly Private & Confidential
Slide 2: Disclaimer
Disclaimer THIS PRESENTATION SHALL NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY SECURITIES IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES OF AMERICA OR ELSEWHERE . This presentation should be read in conjunction with the joint announcement released by OUE Healthcare Limi
Slide 3: Transaction Overview
Transaction Overview Offeror ➢ Treasure International Holdings Pte . Ltd . (the “Offeror ”), which is a wholly owned subsidiary of OUE Limited ➢ Privatisation of OUE Healthcare Limited (the ”Company ”), to be effected through : the proposed acquisition (the "Acquisition ") of all the issued and paid
Slide 4: Rationale for the Scheme
1 Rationale for the Scheme Strictly Private & Confidential 3
Slide 5: Rationale for the Scheme
Rationale for the Scheme Opportunity for Scheme Shareholders to exit their Opportunity for Scheme Shareholders to realise their 1 entire investment in cash at a compelling price and favourable valuation without incurring brokerage costs 2 entire investment in the Scheme Shares, which may otherwise b
Slide 6: Financial Evaluation of the Scheme Consideration
2 Financial Evaluation of the Scheme Consideration Strictly Private & Confidential 5
Slide 7: Share Price of the Company in the Last 5 Years
Share Price of the Company in the Last 5 Years The Scheme Consideration is higher than the closing share price of the Shares in the past five (5) - year period up to and includi ng the Last Trading Day Share price (S$) 0.06 Scheme Consideration of S$ 0.050 0.05 • The Scheme Consideration of S$ 0 .05
Slide 8: Premium to Historical Prices
Premium to Historical Prices Scheme Consideration is at a premium (1) to the Last Transacted Price, one (1) - month, three (3) - month, six (6) - month and 12 - month historical VWAPs (2) and at a premium to the latest unaudited NAV per Share as at 30 June 2026 Scheme Consideration: S$ 0.050 per Sch
Slide 9: OUEH's Low Trading Liquidity and Attractive Privatisation Premium Support the Rationale for Privatisation
OUEH’s Low Trading Liquidity and Attractive Privatisation Premium Support the Rationale for Privatisation Precedent Catalist healthcare privatisation transactions over the last 5 years 12- month Average Daily Trading Volume (% of Total Shares Outstanding) (1) 0.25% 0.22% 0.20% Persistently Low Liqui
Slide 10: Approvals Required and Timeline
3 Approvals Required and Timeline Strictly Private & Confidential 9
Slide 11: The Scheme is Subject to Approval of Scheme Shareholders and Other Conditions
The Scheme is Subject to Approval of Scheme Shareholders and Other Conditions Approval Threshold for the Scheme Head Count Condition Share Value Condition >50% And ≥75% More than 50 % of the Scheme Shareholders present and voting either Scheme Shareholders representing at least 75% in value of the S
Slide 12: Indicative Transaction Timetable
Indicative Transaction Timetable Indicative Date Events 24 August 2026 Joint Announcement of Scheme Mid October 2026 Expected date of first Court hearing (1) to convene the Scheme Meeting End October 2026 Expected date of dispatch of Scheme Document and notice of Scheme Meeting Mid November 2026 Exp
Slide 13: Investor Contact
Investor Contact For any enquires relating to the Scheme, please contact the below Financial Adviser to the Offeror in respect of the Acquisition and the Scheme Maybank Securities Pte. Ltd. Investment Banking & Advisory T: +65 6231 5978 OUE Limited Investor Relations T: +65 6809 6064 E: investorrela
Slide 14: Responsibility Statement
Responsibility Statement Treasure International Holdings Pte . Ltd . - The directors of the Offeror (including any who may have delegated detailed supervision of the preparation of this presentation) have taken all reasonable care to ensure that the facts stated and all opinions expressed in this pr
Slide 15: Sponsor's Statement
Sponsor’s Statement This presentation has been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte . Ltd . (the "Sponsor "). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange ") and the Exchange assumes no responsibility for t
Slide 16: Thank You
THANK YOU Strictly Private & Confidential 15